SAHPRA MedSafetyWeek campaign: Reporting of Side Effects

By HEOR Staff Writer

November 11, 2023

The Importance of Documenting Side Effects

The South African Health Products Regulatory Authority (SAHPRA) is advocating for the usage of the MedSafety app as a means of bolstering efforts to ensure the integrity of medicinal products. #MedSafetyWeek is a global campaign that aims to improve the safety of medications all around the world, and this project is a component of that campaign. The campaign, involving more than 80 regulatory agencies, is a testament to the collective effort to better the healthcare industry.

 

SAHPRA MedSafetyWeek campaign: A Tool for Safer Medicines

Patients, physicians, nurses, and pharmacists are all able to report adverse effects with the help of a powerful tool called the MedSafety app. These reports are absolutely necessary for the continuous monitoring of the medications’ safety. According to Mafora Matlala, the Pharmacovigilance Manager at SAHPRA, “Every report is important in building more knowledge and understanding of the benefits and risks of medicines in clinical use and allows action to be taken to minimise risks.”

Users can download the MedSafety app from the Google Play Store or the Apple App Store, depending on your device. The app allows users to report adverse events and product quality issues. This helps enhance the safety of the healthcare environment overall.

SAHPRA’s commitment to the safety, efficacy, and quality of all health products underlines its ethos. Together, we can make a difference in ensuring safer medicines for all.

Reference url

Recent Posts

Strategic Investment Boosts Medical Device Distribution in Africa

By HEOR Staff Writer

May 5, 2026

Amethis, Proparco, ccap.ai and Vertice management have completed the acquisition of Vertice MedTech Holdings, positioning the company for accelerated expansion as the ...
JNJ-4804 IBD Therapy Proves Effective for Refractory Inflammatory Bowel Disease
JNJ-4804 IBD therapy offers new hope for patients with hard-to-treat inflammatory bowel disease. This co-antibody treatment combines two proven mechanisms in a single injection. It targets IL-23 and TNF-α pathways at once. Recent Phase 2b results support its move into larger trials. Johnson &a...
Transforming Health: The Role of the South African Medical Research Council

By João L. Carapinha

May 4, 2026

South African Medical Research is driving meaningful progress in addressing the region’s most pressing health challenges. What are the priorities of the South African Medical Research Council for shaping the future of health? In a recent interview, President and CEO Ntobeko Ntusi explains how the...